Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126675651 | 12667565 | 1 | I | 201608 | 20160811 | 20160819 | 20160819 | EXP | US-009507513-1608USA007699 | MERCK | 63.00 | YR | M | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126675651 | 12667565 | 1 | PS | BELSOMRA | SUVOREXANT | 1 | Oral | 20 MG, AT BEDTIME | U | 204569 | 20 | MG | TABLET | QD | |||||
| 126675651 | 12667565 | 2 | SS | OXYCODONE | OXYCODONE | 1 | 30 MG, HS | U | 0 | 30 | MG | QD | |||||||
| 126675651 | 12667565 | 3 | SS | SOTALOL. | SOTALOL | 1 | 80 MG, HS | U | 0 | 80 | MG | QD | |||||||
| 126675651 | 12667565 | 4 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 150 MG, HS | U | 0 | 150 | MG | QD | |||||||
| 126675651 | 12667565 | 5 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG, HS | U | 0 | 20 | MG | QD | |||||||
| 126675651 | 12667565 | 6 | SS | RISPERIDONE. | RISPERIDONE | 1 | 20 MG, HS | U | 0 | 20 | MG | QD | |||||||
| 126675651 | 12667565 | 7 | SS | KLONOPIN | CLONAZEPAM | 1 | 1 MG, HS | U | 0 | 1 | MG | QD | |||||||
| 126675651 | 12667565 | 8 | SS | TRILEPTAL | OXCARBAZEPINE | 1 | 300 MG, HS | U | 0 | 300 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126675651 | 12667565 | HO |
| 126675651 | 12667565 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126675651 | 12667565 | Atrial fibrillation | |
| 126675651 | 12667565 | Drug abuse | |
| 126675651 | 12667565 | Eye movement disorder | |
| 126675651 | 12667565 | Haemoptysis | |
| 126675651 | 12667565 | Heart rate decreased | |
| 126675651 | 12667565 | Hyperhidrosis | |
| 126675651 | 12667565 | Lung disorder | |
| 126675651 | 12667565 | Miosis | |
| 126675651 | 12667565 | Rhabdomyolysis | |
| 126675651 | 12667565 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |